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Introduction
Worldwide, prostate cancer is the second most frequently 
diagnosed cancer in men; in 2012, an estimated 1.1 mil-
lion new cases were diagnosed, accounting for 15% of 
the cancers diagnosed in men [1]. With earlier detection 
and effective treatments, more men with prostate cancer 
are living longer postdiagnosis; five- year relative survival 
rates in Australia increased to 93.0% for the years 2007–2011 
[2]. Given the high survival rates for prostate cancer, it 
is important that survivorship issues are addressed.
Men who have been treated for prostate cancer often 
experience high rates of morbidity due to ongoing adverse 
physical effects of treatment, decision- related distress, and 
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Abstract
Understanding the factors that influence adherence to exercise programs is nec-
essary to develop effective interventions for people with cancer. We examined 
the predictors of adherence to a supervised exercise program for participants 
in the ENGAGE study – a cluster randomized controlled trial that assessed the 
efficacy of a clinician- referred 12- week exercise program among men treated 
for prostate cancer. Demographic, clinical, behavioral, and psychosocial data 
from 52 participants in the intervention group were collected at baseline through 
self- report and medical records. Adherence to the supervised exercise program 
was assessed through objective attendance records. Adherence to the supervised 
exercise program was 80.3%. In the univariate analyses, cancer- specific quality 
of life subscales (role functioning r = 0.37, P = 0.01; sexual activity r = 0.26, 
P = 0.06; fatigue r = −0.26, P = 0.06, and hormonal symptoms r = −0.31, 
P = 0.03) and education (d = −0.60, P = 0.011) were associated with adher-
ence. In the subsequent multivariate analysis, role functioning (B = 0.309, 
P = 0.019) and hormonal symptoms (B = −0.483, P = 0.054) independently 
predicted adherence. Men who experienced more severe hormonal symptoms 
had lower levels of adherence to the exercise program. Those who experienced 
more positive perceptions of their ability to perform daily tasks and leisure 
activities had higher levels of adherence to the exercise program. Hormonal 
symptoms and role functioning need to be considered when conducting exercise 
programs for men who have been treated for prostate cancer. 
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the psychological effects of living with cancer [3–5]. Thus, 
improving the quality of life and psychological well- being 
of these men through supportive care interventions such 
as exercise programs is a priority [6]. Exercise has a range 
of benefits for men who have been treated for prostate 
cancer and evidence supports the positive physical and 
psychological outcomes of exercise for this group [6–9]. 
Recommendations for physical activity for cancer survivors 
include at least 150- min per week of moderate intensity 
or 75- min per week of vigorous- intensity aerobic physical 
activity, or an equivalent combination. Two to three weekly 
sessions of resistance training are also recommended [10] 
Most men who have been treated for prostate cancer, 
however, do not achieve recommended levels of physical 
activity [11, 12], in a recent study only 12.3% reported 
sufficient levels [12]. Lifestyle interventions that focus on 
increasing adherence to exercise can help to address low 
levels of participation.
Examination of factors that are associated with adher-
ence to exercise interventions for people with cancer 
will assist in the tailoring of these programs and poten-
tially lead to higher levels of adherence and reduced 
attrition [13, 14]. However, researchers rarely investigate 
predictors of adherence to exercise. [13–15]. Given that 
adherence rates and predictors differ across cancer groups 
and types of exercise intervention (supervised or home- 
based or combination) [13, 16, 17], the examination 
adherence for specific cancer groups and types of inter-
ventions is required [14]. To our knowledge, only one 
study has reported predictors of adherence to an exercise 
program for men treated for prostate cancer and was 
limited to men receiving androgen deprivation therapy 
(ADT) [18]. In that study, Courneya et al. reported that 
three factors independently explained 20.4% of the vari-
ance in adherence: exercise stage of change, age, and 
intention.
This study is a secondary analysis of data from the 
ENGAGE study. The aims of the ENGAGE study were 
to determine the efficacy of a clinician referral and exer-
cise program to improve exercise levels and quality of 
life for men with prostate cancer and the main outcomes 
of the study have been reported previously [19]. Briefly, 
we found a significant positive intervention effect for 
vigorous- intensity exercise; meeting exercise guidelines; 
improved cognitive functioning and a reduction in symp-
toms of depression [19]. The goal of this secondary 
analysis was to examine demographic, clinical, behavioral, 
and psychosocial predictors of adherence to the supervised 
exercise program. Given the lack of research into the 
factors that predict adherence to exercise interventions 
for men treated for prostate cancer, we undertook an 
exploratory approach that included a range of potential 
predictors.
Method
Details of the ENGAGE study methods have been reported 
elsewhere [20] and are briefly presented here. The study 
was a two- armed prospective, multicenter, cluster rand-
omized controlled trial. Ethical approval was obtained 
from Deakin University and each of the health services 
involved in the study. Written informed consent was 
obtained from patients prior to their involvement in the 
study.
Participants and procedure
Participants in this study were adult men who had (a) 
a diagnosis of stage I, II, or III prostate cancer and treated 
with curative intent; (b) completed treatment for prostate 
cancer within the previous 3–12 months (patients on ADT 
were eligible to participate); and (c) the ability to complete 
surveys in the English language. Participants were excluded 
if they had any musculoskeletal, cardiovascular, or neu-
rological disorders deemed absolute contraindications to 
exercise.
Recruitment was conducted at urology and radiation 
oncology outpatients’ clinics within three public health 
services and four private clinics in Melbourne, Australia. 
Patients were identified through health services and private 
clinic patient records and recruited from October 2011 
to June 2013. Patients were informed about the study 
and provided with an information package at their clinical 
consultations. Clinicians randomized to the intervention 
condition provided a referral slip to patients deemed suit-
able and recommended that the patient undertake the 
exercise program. Clinicians randomized to the control 
condition provided usual care regarding physical activity 
advice. Clinicians provided medical clearance prior to the 
patients’ involvement in the study. A study researcher 
later phoned eligible patients to explain participation in 
the study in more detail, answer any questions and gain 
informed consent.
Randomization
Clinicians (i.e., urologists, radiation oncologists, and urol-
ogy nurses) who agreed to be involved in the study were 
randomly allocated using an online random number gen-
erator to either the intervention or control conditions. 
Randomization was conducted by the first author.
Exercise training intervention
We specifically designed the 12- week exercise intervention 
to address the determinants of social cognitive theory 
(SCT) [21, 22] and aimed to increase physical activity 
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participation, based on physical activity guidelines for 
cancer survivors proposed by the American College of 
Sport Medicine [10] and Exercise Sport Science Australia 
[23]. Participants were asked to complete three, up to 
50 min, sessions of exercise training per week. Two of 
these sessions were supervised and conducted with exercise 
trainers who were postgraduate clinical exercise physiology 
students under the supervision of accredited exercise 
physiologists (a tertiary- trained exercise training profes-
sional) and one session was a nonsupervised home- based 
session. Exercise sessions incorporated progressive aerobic, 
resistance, balance, and flexibility exercises and was tailored 
to the needs and ability of participants. Each supervised 
session included 20–30 min of aerobic exercises prescribed 
at 40–70% of maximum heart rate and 4–6 upper and 
lower body resistance exercises, performed in two sets of 
8–12 repetitions. To achieve consistency in exercise pre-
scription, each exercise program included 90° leg press, 
seated chest press, and seated row.
Exercise trainers received training in SCT and were 
instructed to incorporate discussions of the participant’s 
beliefs in their ability to exercise, exercise preferences, 
outcome expectations, goals, and strategies for using facili-
tators and overcoming barriers to performing exercise. 
Exercise trainers were provided with checklists to ensure 
that they were addressing the key topics during exercise 
sessions. The involvement of clinicians in referring men 
to the program provided social support, which was expected 
to increase self- efficacy through increasing men’s beliefs 
in their ability to undertake exercise.
Measures
Outcome variable
The outcome for the secondary analysis was Adherence 
to the Exercise Program, assessed as the percentage of ses-
sions that were attended in the supervised component of 
the exercise program. The percentage of sessions was 
calculated as follows: the number of sessions attended/24 
planned sessions × 100. The number of sessions attended 
was assessed by objective attendance records maintained 
by the exercise trainers in the study. We used an inten-
tion to treat analysis.
Predictor variables
Previously validated scales were used to measure cancer- 
specific quality of life, depressive symptoms, and prostate 
cancer-related anxiety. Cancer-specific quality of life was 
measured using The European Organization for Research 
and Treatment of Cancer core quality of life questionnaire 
(EORTC QLQ- C30, V3) [24] and the prostate tumor- specific 
module (EORTC QLQ- PR25) [25, 26]; Depressive symptoms 
were measured using the 20- item Centre for Epidemiological 
Studies Depression Inventory (CES- D) [27]; Prostate-cancer-
related anxiety was measured using the Memorial Anxiety 
Scale for Prostate Cancer (MAX- PC) [28].
An adapted version of the Leisure Time Exercise 
Questionnaire [29, 30], was used to measure past physical 
activity behavior. Participants were asked to report their 
average weekly duration of light (minimal effort, no per-
spiration), moderate- (not exhausting, light perspiration), 
and vigorous- intensity (heart beats rapidly, sweating) activ-
ity in a typical week in the past month, in addition to 
the frequency. We then calculated the percentage of par-
ticipants achieving ≥150 min per week of moderate plus 
vigorous- intensity physical activity.
Demographic characteristics included age, highest level 
of education, marital status, and body mass index (BMI). 
BMI was calculated from objective weight (kg)/height (m)2. 
Clinical characteristics that were collected included cancer 
stage and number of weeks since treatment completion, 
which were collected from medical records, and treatment 
type (surgery, radiotherapy and/or ADT) and comorbidi-
ties (e.g., high blood pressure, high cholesterol, heart 
disease, arthritis, diabetes, asthma/emphysema, chronic 
pain), which were collected through self- report. Total 
comorbidities were calculated based on the number of 
comorbidities reported.
Data analysis
Two of the 54 intervention participants were excluded 
from this analysis due to insufficient data. Data from 52 
participants were analyzed. Overall, missing data for vari-
ables included in this analysis were less than 1%. The 
amount of missing data that was tolerated and scale cal-
culations were consistent with recommendations for the 
EORTC QLQ- 30 [31], EORTC QLQ- PR25 [26], and CES- D 
[27]. The MAX-PC was calculated if more than 80% of 
items were answered. The cancer- specific quality of life 
subscale ‘Nausea and Vomiting’ was not included in the 
analysis as almost all participants (96.2%) reported that 
they did not experience this symptom. Data for the demo-
graphic and clinical characteristics were included in the 
analysis when data were available for that particular 
participant.
Our main outcome variable was adherence to the struc-
tured exercise training program, expressed as the percentage 
of total sessions. Data were somewhat non- normal, however, 
we made a decision not to transform the data as the tests 
that we used were robust against non- normality [32, 33].
The following variables were dichotomized prior to the 
analyses: highest level of education (categorized as less 
than university degree or university degree or higher), 
relationship status (categorized as partner or no partner), 
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ADT (yes/no), and most recent active treatment (radio-
therapy or surgery).
First, univariate analysis was conducted to examine 
associations between the predictors and adherence using 
t- tests, and Pearson’s correlations, where appropriate. 
Cohen’s d effect sizes were calculated for t- test statistics. 
Due to our small sample size, variables that had statisti-
cally significant or borderline significance (P < 0.10) 
univariate associations with adherence were included in 
the multivariate analysis to examine the independent pre-
dictors of adherence to the exercise program.
The clustering effect of clinicians for adherence to the 
exercise program was moderate (ICC 0.126). We used 
Generalized Estimation Equation Modelling (GEE) with 
exchangeable variance- covariance matrix to adjust for the 
clinician clustering effect. Backwards deletion method was 
used to define the final GEE model. This involved dele-
tion of each of the nonsignificant predictors (starting with 
the largest P value) one at a time until significant vari-
ables remained.
SPSS (V22, Armonk, NY, IBM Corp.) was used for the 
descriptive and univariate analyses. STATA (V13, College 
Station, TX, StataCorp LP.) was used for the GEE analyses.
Results
The flow of participants has been summarized elsewhere 
[19]. Briefly, 15 clinicians (71.0%) agreed to participate 
(8 clinicians were randomized to the intervention condi-
tion and seven were randomized to the control condition). 
In total, 320 eligible patients were approached to participate 
in the study (142 intervention; 178 control), of these, 
147 (46%) consented to be involved in the study [19].
The 52 intervention participants included in this analysis 
ranged in age from 50 to 84 years (M = 67.3, SD = 8.08). 
Most had completed a certificate or diploma (n = 18, 34.6%) 
or university degree (n = 16, 30.8%) and were married or 
living with a partner (n = 45, 86.5%). Their BMI ranged 
from 19.2 to 36.4 (M = 28.6, SD = 3.74, n = 51). Overall, 
16 (30.8%) were treated with surgery only; 15 (28.8%) were 
treated with surgery and radiotherapy; 13 (25.0%) were 
treated with radiotherapy and ADT. The mean time since 
completion of last treatment was 25.5 weeks (SD = 11.37). 
Most participants were cancer stage I (n = 19, 47.5%).
Scores on the CESD scale ranged from 0 to 45 (M = 9.0, 
SD = 9.40) and scores on the MAX-PC ranged from 0 
to 36 (M = 9.1, SD = 8.40). In terms of cancer- specific 
quality of life, participants reported relatively high func-
tional scores and low symptomology. At baseline, 36.5% 
(n = 19) were participating in ≥150 min per week of 
moderate plus vigorous physical activity.
Based on the percentage of sessions attended, mean 
adherence to the structured exercise training program was 
80.3% (SD = 20.145, n = 52). Attrition was 13.0% (n = 7); 
four participants dropped out or withdrew from the pro-
gram (7.4%) and three were lost to follow- up (5.5%).
Participants were asked to record exercise details in an 
exercise diary for the home- based component of the pro-
gram. Among the participants who returned the diary 
(n = 40) and based on the percentage of sessions that 
participants reported, the mean adherence was 77.5% 
(SD = 28.26). Given that 26% of participants did not 
return their diary, we did not have a full dataset to exam-
ine the predictors of adherence to the home- based com-
ponent of the program. The association between adherence 
to the home- based program and adherence to the supervised 
program was low to moderate in strength, but not sta-
tistically significant (r = 0.27, P = 0.096).
The results of the univariate analyses are presented 
in Tables 1 and 2. Factors that were significantly 
Table 1. Behavior and psychosocial factors associations with adherence: 
univariate analyses.
n r P
Memorial Anxiety Scale 52 −0.14 0.34
CES- D 52 −0.05 0.71
QLQ- C30
Global quality of life 52 0.14 0.32
Functional Scales
Physical functioning 52 0.23 0.10
Role functioning 52 0.37 0.01
Emotional functioning 52 0.19 0.17
Cognitive functioning 52 0.14 0.32
Social Functioning 52 0.06 0.65
Symptom Scales/Items
Fatigue 52 −0.26 0.06
Pain 52 0.05 0.72
Dyspnoea 52 0.06 0.66
Financial difficulties 51 −0.16 0.26
Diarrhoea 51 −0.17 0.24
Constipation 51 0.00 0.98
Appetite loss 52 0.15 0.31
Insomnia 52 0.07 0.63
QLQ- PR25
Functional scales
Sexual activity 52 0.26 0.06
Sexual functioning1 19 0.15 0.55
Symptom scales/items
Urinary symptoms 52 0.14 0.32
Bowel symptoms 52 −0.08 0.59
Hormonal symptoms 52 −0.31 0.03
Incontinence aid2 16 0.07 0.80
n t P
Physical Activity
≥150 min per week3 52 −.585 0.56
1Items were conditional on being sexually active.
2Item conditional on requiring an incontinence aid.
3Cohen’s d = −0.172.
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associated with adherence to the exercise program were 
as follows: cancer- specific quality of life factors: role 
functioning (r = 0.37 P = 0.01, n = 52), sexual activity 
(r = 0.26, P = 0.06, n = 52), fatigue (r = −0.26, P = 0.06, 
n = 52), hormonal symptoms (r = −0.31, P = 0.03, 
n = 52), and level of education (t = −2.65, P = 0.01, 
n = 52),.
Significant univariate factors were entered as a single 
block into a GEE model. None of the individual variables 
significantly predicted adherence. Following a process of 
backward variable selection, hormonal symptoms 
(B = −0.483, P = 0.054, 95% CI = −0.976 to .009) and 
role functioning (B = 0.309, P = 0.019; 95% CI = 0.051–
0.568) were the only significant predictors of adherence 
(Table 3). Findings suggested that a 10- point increase in 
role functioning (scale range 0–100) was associated with 
a 3% increase in adherence and a 10- point increase in 
hormonal symptoms (scale range 0–100) was associated 
with a 5% decrease in adherence.
Discussion
We examined the predictors of adherence to a supervised 
exercise program for men treated for prostate cancer 
enrolled in a multicenter cluster randomized controlled 
trial (RCT) and addressed a significant shortcoming in 
the literature [13, 14]. We examined a range of potential 
predictors of exercise program adherence, including demo-
graphic, clinical, behavioral, and psychosocial factors. Level 
of education and several cancer- specific quality of life 
factors predicted adherence to the exercise program in 
univariate analyses, in subsequent multivariate analyses, 
role functioning and hormonal symptoms independently 
predicted adherence to the program.
A novel finding of our study was that men who expe-
rienced more severe hormonal symptoms had lower adher-
ence to the exercise program. Men who experience 
hormonal symptoms, which are adverse effects of ADT 
[5], may require additional physical and emotional sup-
port and assistance to facilitate their ongoing participation 
in exercise programs. For example, flexibility in the delivery 
and modifying the intensity of the exercise program when 
symptoms are present. Although our finding on the effect 
of hormonal symptoms in men with prostate cancer is 
new, Courneya et al. [34] recently found that hormonal 
symptoms were negative predictors of adherence to a 
supervised exercise program for women undergoing chemo-
therapy treatment for breast cancer. The influence of 
hormonal symptoms on exercise participation warrants 
further investigation; it is possible that the severity of 
adverse effects from ADT is a more salient factor than 
the existence of the treatment itself in reducing adherence 
to exercise training. Furthermore, adverse effects of ADT 
may exacerbate the impact of other forms of treatment 
on quality of life [35].
We also found that men who experienced more posi-
tive role functioning had higher levels of adherence to 
the exercise program. Role functioning refers to the patient’s 
ability to pursue activities such as work or other leisure 
activities and therefore it is not surprising that those who 
had higher level of functioning in this area would also 
be more able to adhere to an exercise program. It is 
possible that experiencing fatigue and hormonal symptoms 
might reduce the patient’s ability to participate in daily 
activities, therefore influencing participation in an exercise 
program.
Fatigue, sexual activity, and level of education were 
significantly associated with adherence in univariate analy-
ses, but not in the subsequent multivariate analysis. This 
result was similar to a previous study of men treated for 
prostate cancer, which showed that prostate cancer- specific 
quality of life and fatigue predicted adherence to a struc-
tured exercise program in univariate analyses, although 
these factors were not significant in subsequent multivariate 
analysis [18]. Fatigue is regularly experienced by cancer 
patients [36] and has been cited as a barrier to physical 
activity for people living with cancer, including men with 
Table 2. Demographic and clinical characteristics associations with ad-
herence: univariate analyses.
n r P
Comorbidities 49 −0.08 0.58
Age 52 −0.01 0.92
Body mass index (BMI) 51 −0.11 0.45
Weeks since treatment completion 52 −0.10 0.48
Cancer Stage 40 0.088 0.59
n t P
Relationship status 52 0.32 0.751
Surgery or radiotherapy 52 −1.62 0.112
ADT treatment 52 1.62 0.123
Education 52 −2.65 0.014
Cohen’s d effect sizes:
1relationship status: 0.130;
2Surgery or radiotherapy −0.497;
3Androgen deprivation therapy (ADT) treatment = 0.614;
4education = −0.60.
Table 3. Gee model of quality of life factors on adherence to the 
 exercise program.
 95% CI
B z P Lower Upper
Model
 Role functioning 0.309 2.34 0.019 0.051 0.568
 Hormonal symptoms −0.483 −1.92 0.054 −.976 .009
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prostate cancer [37]. In our study, men who had com-
pleted a University degree achieved a higher level of 
adherence to the program. Although level of education 
has rarely been identified as a predictor of adherence to 
supervised exercise programs in cancer survivors, a study 
of women with breast cancer undergoing chemotherapy 
found that education significantly predicted adherence 
[38]. Furthermore, studies of noncancer populations con-
sistently show that higher levels of education are associated 
positively with participation in physical activity [39–41]. 
People with higher levels of education may be more 
informed of the health consequences of certain lifestyle 
behaviors, leading them to exercise more often [41]. The 
influence of education is likely to be more pronounced 
in older age because people with low education tend to 
rely on employment as a major source of physical activ-
ity, which results in declines in physical activity as they 
move through early old age and transition out of the 
workforce [42].
It is worth noting that, in univariate analyses, several 
factors that were not statistically significance had medium 
effect sizes. This suggests that we did not have enough 
power to detect significance. The factors with medium 
effect sizes included cancer- specific quality of life, physical 
functioning (r = 0.23); ADT (d = 0.614; men treated 
with ADT had lower adherence), and most recent active 
treatment (d = −0.497; men whose most recent treatment 
was radiotherapy had lower adherence). Consideration 
should be given to these factors in studies with larger 
sample sizes.
There is little consensus with regard to factors that are 
associated with adherence to supervised exercise programs 
and in many studies, including ours, only a modest amount 
of the variance in adherence is explained by patient- related 
factors [38, 43, 44]. This might be due to external fac-
tors, such as the nature of supervised exercise programs, 
which typically have a high level of patient support and 
features that facilitate adherence and minimize drop out. 
The factors inherent in supervised exercise programs are 
likely to result in high adherence and may ameliorate the 
potential influence of patient related factors in program 
adherence [17, 44]. Based on SCT, our study incorporated 
behavior change techniques, including a clinician referral, 
setting program goals, prompting practice and self- 
monitoring. A recent review of the literature suggested 
that such practices were related to higher levels of adher-
ence to exercise programs for people with cancer [45]. 
Thus, incorporating behavior change techniques may also 
explain the high levels of adherence to the exercise 
program.
We did not assess predictors of adherence to the home- 
based program as 26% of participants did not complete 
and return their physical activity diary. We did, however, 
examine the association between participation in the home- 
based sessions and supervised sessions and this association 
was low to moderate in strength and not significant. It 
is difficult to speculate on whether different factors would 
have predicted adherence to the home- based program 
compared to the supervised program. The patient- related 
factors that we examined, however, may have been stronger 
predictors of the home- based program because these unsu-
pervised sessions did not have the structure and social 
support inherent in the supervised program.
This study was strengthened by the use of objective 
measures of exercise session adherence and inclusion of 
a range of potential factors that might influence adher-
ence. A limitation of our study was the sample size. 
Although comparable to similar studies of supervised 
exercise programs [17, 43, 44], our sample size was rela-
tively small in terms of detecting statistical significance 
in predicting adherence.
In summary, we suggest that factors related to cancer- 
specific quality of life may predict adherence to supervised 
exercise programs for men treated for prostate cancer. 
The quality of life of men entering exercise programs 
should be assessed so that symptoms, including fatigue 
and hormonal symptoms that impact on their ability to 
perform daily activities, can be addressed. We also suggest 
that it would be useful to examine factors external to 
the patient, including the nature of the exercise program, 
to further develop our understanding of adherence to 
supervised exercise programs.
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